• Electrolyte Panel, Serum
  • Hereditary Breast Cancer Gene Mutation Panel, NGS (BreastNext®)
  • Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
  • Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Confirmation
  • Cancer Antigen Profile
  • Blood Culture (Bloodstream Infection) Pathogen and Resistance Gene Panel, Molecular
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • Urea Nitrogen (BUN) Creatinine Ratio
  • Digoxin, Total, Serum
  • Reticulocyte Count
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
Medical Test

ICD10
Access to FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx is restricted.
Loading...